Hai-Lian Bi

1.1k total citations
27 papers, 848 citations indexed

About

Hai-Lian Bi is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Oncology. According to data from OpenAlex, Hai-Lian Bi has authored 27 papers receiving a total of 848 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 11 papers in Cardiology and Cardiovascular Medicine and 6 papers in Oncology. Recurrent topics in Hai-Lian Bi's work include Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (5 papers) and Cardiac Fibrosis and Remodeling (4 papers). Hai-Lian Bi is often cited by papers focused on Ubiquitin and proteasome pathways (9 papers), Peptidase Inhibition and Analysis (5 papers) and Cardiac Fibrosis and Remodeling (4 papers). Hai-Lian Bi collaborates with scholars based in China. Hai-Lian Bi's co-authors include Hui‐Hua Li, Huijian Wu, Xin Xie, Xiang Ao, Alan K. Chang, Jie Du, Ying Liu, Feng Zhao, Yunlong Xia and Hongxia Wang and has published in prestigious journals such as PLoS ONE, Oncogene and Scientific Reports.

In The Last Decade

Hai-Lian Bi

26 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hai-Lian Bi China 17 534 147 133 117 104 27 848
Jinjiang Pang United States 20 563 1.1× 89 0.6× 152 1.1× 87 0.7× 80 0.8× 37 1.1k
Ju Youn Beak United States 14 482 0.9× 105 0.7× 140 1.1× 37 0.3× 54 0.5× 17 874
Tsugumichi Saito Japan 18 568 1.1× 120 0.8× 74 0.6× 62 0.5× 103 1.0× 69 1.1k
Xiao-Qing Dai Canada 21 795 1.5× 121 0.8× 56 0.4× 102 0.9× 126 1.2× 42 1.5k
Traci Marin United States 16 589 1.1× 60 0.4× 89 0.7× 138 1.2× 148 1.4× 20 930
Zhiyu Yang Australia 17 286 0.5× 86 0.6× 64 0.5× 98 0.8× 84 0.8× 41 701
Nita Sachan United States 7 552 1.0× 54 0.4× 122 0.9× 53 0.5× 98 0.9× 9 721
Erik Zmuda United States 13 356 0.7× 47 0.3× 66 0.5× 71 0.6× 113 1.1× 18 769
Kristin Pogoda Germany 19 731 1.4× 51 0.3× 44 0.3× 75 0.6× 42 0.4× 29 980

Countries citing papers authored by Hai-Lian Bi

Since Specialization
Citations

This map shows the geographic impact of Hai-Lian Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hai-Lian Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hai-Lian Bi more than expected).

Fields of papers citing papers by Hai-Lian Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hai-Lian Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hai-Lian Bi. The network helps show where Hai-Lian Bi may publish in the future.

Co-authorship network of co-authors of Hai-Lian Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Hai-Lian Bi. A scholar is included among the top collaborators of Hai-Lian Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hai-Lian Bi. Hai-Lian Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xie, Xin, Shihao Wang, Xiaoxue Zhu, et al.. (2024). Administration of USP7 inhibitor p22077 alleviates Angiotensin II (Ang II)-induced atrial fibrillation in Mice. Hypertension Research. 47(5). 1309–1322. 4 indexed citations
2.
Bi, Hai-Lian, Yan Wang, Zhijie Liu, et al.. (2024). Pinobanksin ameliorated DSS-induced acute colitis mainly through modulation of SLC7A11/glutathione-mediated intestinal epithelial ferroptosis. Food & Function. 15(9). 4970–4982. 6 indexed citations
3.
Li, Pang‐Bo, et al.. (2024). Psmb8 inhibits mitochondrial fission and alleviates myocardial ischaemia/reperfusion injury by targeting Drp1 degradation. Cell Death and Disease. 15(11). 803–803. 2 indexed citations
5.
Yu, Xiaohong, et al.. (2022). Cardiac-specific knockdown of Bhlhe40 attenuates angiotensin II (Ang II)-Induced atrial fibrillation in mice. Frontiers in Cardiovascular Medicine. 9. 957903–957903. 10 indexed citations
6.
Jiang, Yinong, Hai-Lian Bi, Chenglin Li, et al.. (2022). Rutaecarpine Inhibits Doxorubicin-Induced Oxidative Stress and Apoptosis by Activating AKT Signaling Pathway. Frontiers in Cardiovascular Medicine. 8. 809689–809689. 17 indexed citations
7.
Wang, Yu, Shihao Wang, Xiaohong Yu, et al.. (2022). Administration of USP7 inhibitor P22077 inhibited cardiac hypertrophy and remodeling in Ang II-induced hypertensive mice. Frontiers in Pharmacology. 13. 1021361–1021361. 16 indexed citations
8.
Xie, Xin, Tingting Shen, Hai-Lian Bi, et al.. (2022). Melatonin inhibits angiotensin II–induced atrial fibrillation through preventing degradation of Ang II Type I Receptor–Associated Protein (ATRAP). Biochemical Pharmacology. 202. 115146–115146. 8 indexed citations
9.
Bi, Hai-Lian, Xiaoli Zhang, Xin Xie, et al.. (2020). The deubiquitinase UCHL1 regulates cardiac hypertrophy by stabilizing epidermal growth factor receptor. Science Advances. 6(16). eaax4826–eaax4826. 74 indexed citations
10.
Xie, Xin, Hongxia Wang, Nan Li, et al.. (2020). Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy. Frontiers in Pharmacology. 11. 885–885. 12 indexed citations
11.
Chen, Chen, Qiu‐Yue Lin, Yan Xiao, et al.. (2018). Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biology. 20. 390–401. 78 indexed citations
12.
Shu, Qing, et al.. (2018). Administration of ubiquitin-activating enzyme UBA1 inhibitor PYR-41 attenuates angiotensin II-induced cardiac remodeling in mice. Biochemical and Biophysical Research Communications. 505(1). 317–324. 12 indexed citations
13.
Wen, Yan, Hai-Lian Bi, Lixin Liu, et al.. (2017). Knockout of immunoproteasome subunit β2i ameliorates cardiac fibrosis and inflammation in DOCA/Salt hypertensive mice. Biochemical and Biophysical Research Communications. 490(2). 84–90. 31 indexed citations
14.
Bi, Hai-Lian, Xiao‐Yan Bai, Zhaowei Xu, et al.. (2015). DEC1 regulates breast cancer cell proliferation by stabilizing cyclin E protein and delays the progression of cell cycle S phase. Cell Death and Disease. 6(9). e1891–e1891. 58 indexed citations
15.
Zhao, Feng, Xiao‐Yan Bai, Hai-Lian Bi, et al.. (2015). DACH1 inhibits SNAI1-mediated epithelial–mesenchymal transition and represses breast carcinoma metastasis. Oncogenesis. 4(3). e143–e143. 70 indexed citations
16.
Bi, Hai-Lian, Shujing Li, Miao Wang, et al.. (2014). SUMOylation of GPS2 protein regulates its transcription-suppressing function. Molecular Biology of the Cell. 25(16). 2499–2508. 27 indexed citations
17.
Chang, Alan K., Ming‐Xi Zang, Hai-Lian Bi, et al.. (2014). Induction of the CLOCK Gene by E2-ERα Signaling Promotes the Proliferation of Breast Cancer Cells. PLoS ONE. 9(5). e95878–e95878. 71 indexed citations
18.
Ao, Xiang, Alan K. Chang, Chunhua Yang, et al.. (2012). CLOCK is a substrate of SUMO and sumoylation of CLOCK upregulates the transcriptional activity of estrogen receptor-α. Oncogene. 32(41). 4883–4891. 59 indexed citations
19.
Li, Shujing, Chunhua Yang, Hai-Lian Bi, et al.. (2012). The transcriptional activity of co‐activator AIB1 is regulated by the SUMO E3 Ligase PIAS1. Biology of the Cell. 104(5). 287–296. 20 indexed citations
20.
Li, Shu-Jing, Hai-Lian Bi, Chunhua Yang, et al.. (2011). SUMOylation of DEC1 Protein Regulates Its Transcriptional Activity and Enhances Its Stability. PLoS ONE. 6(8). e23046–e23046. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026